Survival comparison of stage IIA rectal cancer with or without neoadjuvant therapy: a SEER database analysis with propensity score matching.

Yan, Han; Wang, Peng-Yuan; Wu, Ying-Chao; Liu, Yu-Cun

Yan, Han; Wang, Peng-Yuan; Wu, Ying-Chao; Liu, Yu-Cun.

Afiliação

Yan H; Department of General Surgery, Peking University First Hospital, Beijing, China.
Wang PY; Department of General Surgery, Peking University First Hospital, Beijing, China.
Wu YC; Department of General Surgery, Peking University First Hospital, Beijing, China.
Liu YC; Department of General Surgery, Peking University First Hospital, Beijing, China.

J Gastrointest Oncol ; 13(5): 2293-2305, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36388673

Palavras-chave

Stage IIA; Surveillance, Epidemiology, and End Results database (SEER database); neoadjuvant therapy; propensity score matching (PSM); rectal cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article